Trial ID or NCT#

NCT02202434

Status

RECRUITING

Purpose

The objective of this study is to evaluate the safety and effectiveness of the Lotus™ Valve System for transcatheter aortic valve replacement (TAVR) in symptomatic subjects with calcific, severe native aortic stenosis who are considered at extreme or high risk for surgical valve replacement.

Investigator(s)

Alan C. Yeung, MD
Michael Fischbein, MD
William Fearon, MD
D. Craig Miller, MD

Contact us to find out if this trial is right for you.

CONTACT

Leigh Trautman, RN
(650) 725-3931